chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: FLUX
Symptoms: Muscular weakness, Pain
Clinical narrative: Patient experienced weakness in left hand, with pain from the elbow to the wrist.
Age: 51.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Hypokinesia, Influenza like illness, Injection site swelling, Myalgia, Pyrexia
Clinical narrative: The pt developed extreme flu-like symptoms. Every muscle ached and couldn't move or get comfortable for 3 days. Fever with Tylenol was 101.5F, without ? Arm at sight of shot and the whole upper arm was swollen. Both shots were given in the same arm.
Age: 2.0
Sex: F
Vaccine: DTAP, PNC
Symptoms: Urticaria
Clinical narrative: Within two to three minutes of receiving the vaccinations, the patient was noted to have hives on his face. He was examined by Dr. who noted that the patient's lungs were clear. Treatment consisted of an injection of Benadryl (25 mg). The patient was observed for 30 minutes. There was no adverse reaction to treatment. By the end of the day, the patient was free of the hives.
Age: 0.5
Sex: F
Vaccine: DTAP, HEP, HIBV, PNC
Symptoms: Staring, Tremor
Clinical narrative: 15 minutes, post vax, the mother stated that the pt had "shivering" for about 30 seconds, alert but stared off for several seconds. No fever. Alert just after. Had a 2nd episode, 3 hours later. She was seen at the office and had episode. MD at bedside but did not note any shaking. Pt was looking off for several seconds but very alert. Neuro exam was normal.
Age: 49.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: The pt's arm swelled up and turned red. It was swollen from the shoulder to the middle of lower left arm (pneumonia shot). Took antibiotics.
Age: 59.0
Sex: M
Vaccine: FLU3
Symptoms: Pulmonary congestion, Rhinorrhoea
Clinical narrative: 12/10/2001-Onset of congestion and runny nose. No fever, no sore throat, no malaise, no muscle aches. The patient went to the doctor because they were "very prone to bronchitis" He was told that he had a cold and was prescribed Ampicillin. The patient is aware that the vaccination doesn't protect against URI. He just followed CDC's info on us (VAERS)
Age: 1.0
Sex: F
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Chills, Eye movement disorder, Tremor
Clinical narrative: After the patient received the vaccination, her mother spoke to the ARNP about the fact that she was currently pregnant. After talking with the WIC staff, approximately 1 hour later, the patient and her mother left the building and drove away. While in the car, the mother notice that the patient was rigid, shaking, eyes rolling back. She took her directly to the ER. It took about two minutes to get there. In the ER, IVs were started and labs were drawn. The patient responded immediately, but was drowsy for the rest of the day. By the time the patient was discharged she was alert and crying.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Eye oedema, Face oedema, Throat tightness
Clinical narrative: 11/18/2001-at 1600, three hours post-vaccination, the patient's eyes and lips began to swell. She took 50 mg of Benadryl p.o. at home and then  fell asleep. She awoke at 2000 with chest and throat tightness. At 2100, she went to the ER c/o wheezing and throat tightness. She received 2 doses of epinephrine, thirty minutes apart and 50 mg Benadryl IV
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Rash
Clinical narrative: Patient experienced an itchy rash on her arms and legs, along with underarm soreness in the area of her lymph nodes.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Patient experienced bright red rash on both legs
Age: 59.0
Sex: F
Vaccine: FLUX
Symptoms: Myalgia, Pyrexia, Rash
Clinical narrative: Patient experienced a rash on left arm, a fever and soreness for a day and a half.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Hypernatraemia, Pyrexia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Eye disorder, Hypernatraemia, Hypoglycaemia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Laboratory test abnormal, Pyrexia, White blood cell count increased
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hypoglycaemia, Laboratory test abnormal
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Pyrexia, White blood cell count increased
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Hypernatraemia, Hyperventilation, Hypoglycaemia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hyponatraemia, Ketosis, Laboratory test abnormal, Pyrexia, Tachycardia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Blood urea increased, Convulsion, Diarrhoea, Hyperchloraemia, Hypernatraemia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Hypoglycaemia, Platelet count increased, Pyrexia, Strabismus, White blood cell count increased
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Diarrhoea, Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Dyskinesia, Eye movement disorder, Pyrexia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC, DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Pyrexia
Clinical narrative: On 28-NOV-2001, the infant received her second injection of Infanrix. On that date she also received her second injections of Prevnar, Comvax and her firsr injection of IPOL. On 30-NOV-2001, one day post vaccination, she experienced a seizure characterized by her eyes rolling back and jerkiing of her shoulders and chest "on and off" for 20 minutes. She had a fever of 104 degrees F. She also experienced diarrhea. She was taken was taken to the local ER and hospitalised. The infant was treated with Ibuprofen(Motrin), paracetamol (Tylenol), Lorazepam, phenytoin and ceftriaxone. The events resolved that day. The immunizing physician considered the events to be moderate in severity and possibly related to Infanrix administration.  The Infanrix series was discontinued.  Comment: this is one of two infants from this facility who experienced seizure and fever following receipt of Infanrix or the concomitant vaccine. The reporter indicated that the infants received Infanrix lot DTPA9521A2; however this not a valid lot number.
Age: 73.0
Sex: F
Vaccine: HEPA
Symptoms: Dysgeusia, Laboratory test abnormal, Nausea, Pain, Vomiting
Clinical narrative: On 29-OCT-2001 the pt received her first injection of Havrix. She reported that on 30-OCT-2001 she experienced a "funny taste" in her mouth, nausea, vomiting and pain in her buttocks. She was seen by a physician, who reportedly determined that the pt's copper levels are extremely elevated. On 20-DEC-2001, the pt reported that events were improved. Elevated copper levels are considered medically serious.
Age: 47.0
Sex: M
Vaccine: LYME
Symptoms: Anaemia, Arthralgia, Bone disorder, Chest pain, Congenital anomaly
Clinical narrative: During the past year, I started to be less mobile. I could not turn my head, my back would not bend and I became very ill with a fever and chest and joint pain. The stiffening started shortly after the last shots and the fever began 5 months after the last shot. My fevers lasted almost 3 months. I went through many tests to try to find out what was wrong. 7/23/02 Hospital d/c summary notes add diagnosis of anemia. 8/22/02 Review of more complete hospital records indicates additional symptom of exertional dyspnea.
Age: 47.0
Sex: M
Vaccine: LYME
Symptoms: Dyspnoea, Hypokinesia, Musculoskeletal stiffness, Pyrexia, Red blood cell sedimentation rate increased
Clinical narrative: During the past year, I started to be less mobile. I could not turn my head, my back would not bend and I became very ill with a fever and chest and joint pain. The stiffening started shortly after the last shots and the fever began 5 months after the last shot. My fevers lasted almost 3 months. I went through many tests to try to find out what was wrong. 7/23/02 Hospital d/c summary notes add diagnosis of anemia. 8/22/02 Review of more complete hospital records indicates additional symptom of exertional dyspnea.
Age: 47.0
Sex: M
Vaccine: LYME
Symptoms: Tendon disorder
Clinical narrative: During the past year, I started to be less mobile. I could not turn my head, my back would not bend and I became very ill with a fever and chest and joint pain. The stiffening started shortly after the last shots and the fever began 5 months after the last shot. My fevers lasted almost 3 months. I went through many tests to try to find out what was wrong. 7/23/02 Hospital d/c summary notes add diagnosis of anemia. 8/22/02 Review of more complete hospital records indicates additional symptom of exertional dyspnea.
Age: 0.2
Sex: F
Vaccine: DTAP, HBHEPB, IPV
Symptoms: Irritability, Pyrexia, Rash, Sleep disorder
Clinical narrative: 24 to 48 hours, post vax, the pt developed a fever, rash and was fussy. She was also sleeping more than usual.
Age: 6.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: The pt was dx'd with chickenpox on 12/27/01. She received the Varivax vaccine on 7/10/96.
Age: 34.0
Sex: F
Vaccine: HEP, HEPA
Symptoms: Arthralgia, Myalgia, Swelling
Clinical narrative: The pt developed muscle and joint pain. Her left wrist was especially sore and swollen area on inner forearm. (Naproxen for 10 days with no results)
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: Left thigh swollen, hard to touch, painful and red on the day after vaccine given. Seen in ER and was given Keflex po.
Age: 25.0
Sex: F
Vaccine: SMALL
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: On 12/23/2001, nine days post vaccination, the patient developed a painful erythema,edema, which was warm to the touch at the vaccine injection site. Treatment consisted of a z pack #1. All symptoms diminished by 12/25/2001.
Age: 1.2
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Erythema, Injection site induration, Oedema
Clinical narrative: 01/02/2002, patient examine by PCP. PCP noted erythematous edematous area on left leg. This area had an induration of 6 cm and erythema of 8 cm.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Balance disorder, Eye movement disorder
Clinical narrative: Ten to fifteen seconds after receiving the hepatitis vaccine, the patient's eye rolled backwards and he lost his balance, falling off the chair in which he was sitting. After resting on the examination table for a while, patient recovered without any treatment.
Age: 59.0
Sex: F
Vaccine: FLUX
Symptoms: Pain
Clinical narrative: As the nurse was giving me the shot, a severe pain went creeping down my arm. When it reached my hand, it felt like an explosion going off. I have had a very painful arm for the past six weeks. At first, I had to carry my arm around. It does seem to be getting better.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Dizziness, Hot flush
Clinical narrative: Patient c/o of a warm flush feeling, tight throat and dizziness. Pulse to 146. Treated  with two 25 mg Benadryl capsules
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Nasal congestion, Pyrexia, Rhinorrhoea
Clinical narrative: Patient experienced a 101 degree F fever, loss of appetite, "head cold" type symptoms (congestion, excess mucous, cough. He was treated with expectorant, cough suppressant, decongestant, antihistamine, and eventually antibiotics for an ear infection.
Age: 75.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Influenza like illness
Clinical narrative: Patient experienced flu symptoms for a period of time lasting more than 36 hours. There was no fever. She was treated with aspirin and bed rest.
Age: 1.0
Sex: F
Vaccine: MMR, PNC, VARCEL
Symptoms: Convulsion, Febrile convulsion
Clinical narrative: A few days post-vaccination, patient experienced a fever of 101 degrees f. She was then fine until around 1700 hours on the 14th. Her fever then continued and escalated until around 0130 on 11/15/2001, when she experienced a fever of 103-104 degrees F. she then had a seizure and was transported to the hospital. At the hospital she was treated with Motrin.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Abortion
Clinical narrative: 11/11/2001-Seven weeks into her pregnancy, the patient had a spontaneous abortion.
Age: 41.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Pruritus
Clinical narrative: On 12/07/2001, patient c/o dime-sized abrasion-like local reaction. He states it baecame red and "itchy".
Age: 71.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Feeling hot, Injection site erythema
Clinical narrative: Patient received the pneumococcal vaccine on 12/26/2001. They then experienced erythemia and warmth on the upper part (shoulder to elbow) of the arm which the vaccine was administered.
Age: 86.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Feeling hot, Pyrexia
Clinical narrative: the patient experienced a fever of 101 degrees F, along with enduration, redness and warmth at the injection site. Physician informed-no treatment ordered.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Strabismus, Tremor, White blood cell count increased
Clinical narrative: 10/24/01-Patient experienced tremors which were more severe on the right side of his body. He also had a headache and his eyes were involuntary cross-eyed.  10/26/2001-The neurologist did a lumbar puncture and a WBC. (See results below) 10/27/01- All symptoms were resolved.
Age: 58.0
Sex: F
Vaccine: LYME
Symptoms: Arthritis, Conjunctivitis, Rash
Clinical narrative: On 11/15/2001, the vaccine received an injection of the Lyme vaccine. It wasn't known if she had received previous injection of the vaccine. On 11/25/2001, 10 days post vaccination, she experienced conjuctivitis, rash and arthritis. She was seen by the physician. the diagnosis of arthritis was based on the unspecified symptoms experienced by the vaccinee, no laboratory analyses were performed. Treatment was not specified. The events persisted as of 12/21/2001.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Dyspnoea, Insomnia, Neuralgia, Pain, Pruritus
Clinical narrative: A 45 year old male pharmacist reported that he received Flu-Shield (1997-1998) on 10/24/97. Within 15 minutes, post vax, he developed welts and itching on his chest and upper extremities. He was immediately seen by a Dermatologist who administered epinephrine and an inhaler (unspecified). He was also treated with prednisone and an inhaler (unspecified). The symptoms lasted about 3 weeks. The reporter noted that he has received flu shots virtually every year since 1975 and this was the 1st time he developed a reaction. This case was considered serious since hypersensitivity that required treatment with epinephrine was considered to be "Other Important Medical Events" in this case. No additional information was available as of the date of this report. Follow-up information received on 12/28/01 states that the pt was treated by a dermatologist who administered epinephrine, prednisone and albuterol inhaler. According to the dermatologist, the pt also developed rash, neuralgia, dyspnea, difficulty in sleeping and pain. The symptoms lasted for 4 weeks and the pt recovered.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: A 45 year old male pharmacist reported that he received Flu-Shield (1997-1998) on 10/24/97. Within 15 minutes, post vax, he developed welts and itching on his chest and upper extremities. He was immediately seen by a Dermatologist who administered epinephrine and an inhaler (unspecified). He was also treated with prednisone and an inhaler (unspecified). The symptoms lasted about 3 weeks. The reporter noted that he has received flu shots virtually every year since 1975 and this was the 1st time he developed a reaction. This case was considered serious since hypersensitivity that required treatment with epinephrine was considered to be "Other Important Medical Events" in this case. No additional information was available as of the date of this report. Follow-up information received on 12/28/01 states that the pt was treated by a dermatologist who administered epinephrine, prednisone and albuterol inhaler. According to the dermatologist, the pt also developed rash, neuralgia, dyspnea, difficulty in sleeping and pain. The symptoms lasted for 4 weeks and the pt recovered.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Cranial nerve disorder, Disorientation, Ear disorder, Facial palsy, Infection
Clinical narrative: It was reported that a 64 year old male pt received a Fluzone SV '01-'02 vaccination administered IM in his arm on 9/24/01 between 12:55-13:00. At approx. 13:15, that same day, the pt became disoriented and was unable to drive. The pt went to the doctor's office within a few days and was dx'd with an ear infection (left side). The ear infection continued to worsen and the pt was hospitalized on 10/12/01. Tests ran had a cranial nerve infection, Bell's Palsy. Spinal tap is pending. The pt is home as of this date, 12/28/01. The pt is scheduled to see his doctor next week to discuss options.
Age: 62.0
Sex: M
Vaccine: FLUX, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a pharmacist and an LPN concerning a 62 year old white male with a single kidney who on 10/30/01 was vaccinated with pneumococcal vaccine 23 polyvalent (lot 636849/0944K) in the right deltoid along with the influenza virus vaccine in the left deltoid. A few hours, post vax, the pt phoned the physician's office and complained of the right deltoid shot area being red, swollen and painful. The pt was instructed to take diphenhydramine hydrochloride (Benadryl), 50mg, take an unspecified anti-inflammatory and to put ice of the area and to follow-up "PRN". The pt returned to the physician's office on 10/31/01 where his whole arm was red, swollen and painful. The pt was treated with methylprednisolone sodium succinate (Solu-Medrol) 125mg and was prescribed prednisone 20mg, BID X 1 day then 20mg, daily X 1 day. He was instructed to take ibuprofen 600mg TID, Benadryl 25mg q 6 hours PRN, apply cold packs and to call if not markedly improved or resolved. The pt went to the ER (no further details provided). The LPN considered the swelling, redness and pain to be disabling and an "Other Important Medical Event". The pharmacist reported on another pt (WAES01110021). Additional information is not expected.
Age: 6.0
Sex: M
Vaccine: PNC
Symptoms: Arrhythmia, Hypotension, Type IV hypersensitivity reaction
Clinical narrative: A physician reported that a pediatric heart transplant pt with acute cellular rejection, received 1st dose of Prevnar on 12/5/01 during a routine cardiac catheterization while under general anesthesia. The Prevnar administration was "immediately" followed by a dose of morphine sulfate (ESI Lederle). Approx. 30-60 seconds, post vax, the pt developed hypotension and "very pronounced" and "unusual" ST segment changes that resolved after approx. 5 minutes, without treatment. The attending cardiologist suspected administration of morphine sulfate and other unspecified anesthetic agents combined with the pt's lack of "proper" cardiac innervation and circulatory compensatory feedback as a cause of the events. The reporter noted that the pt's acute cellular rejection may have contributed to the ST segment changes. The reporter indicated that the events were "unlikely to be related" to Prevnar administration. Hypotension and ST segment changes were considered to be "Other Important Medical Events". Follow-up information received from the physician on 2/01/2002 identified the patient as a 6-year-old male. The physician idicated that the ST segment changes in lead V2 normalized after the patient's blood pressure normalized. The reportered noted that the patient's acute cellular rejection (3A) was determined by the results of an endomyocardial biopsy performed on 12/06/2001. The reportered considered the events to be life-threatening.
Age: 3.0
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, MMR
Symptoms: Autism, Drug toxicity, Speech disorder
Clinical narrative: This report is concerning a 42 month old male who on an unspecified date was vaccinated with 1 dose of MMRII and Hib conjugate vaccine (mfr unk), Hep-B vaccine, recomb (Engerix-B), diphtheria toxoid/pertussis vaccine/teta (mfr unk), poliovirus vaccine (IPOL) and tuberculin purified protein derivative (PPD Tine Test). At 3.5 years of age, in approx. 12/01, the pt had a delay in the ability to speak and had a vocabulary of approx. 12 words. It was reported that the child "was evaluated by the local school district, which stated that the child shows signs of autism and that can be caused by mercury poisoning". It was reported that the pt had not been evaluated by a physician. This was originally reported by the pt's father. Upon internal review, the pt's autism and mercury poisoning were considered to be "Other Important Medical Events". Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: HEP
Symptoms: Abnormal behaviour, Apathy, Autism, Neurodevelopmental disorder, Speech disorder
Clinical narrative: This was originally reported by a consumer concerning her 15 month old son who, on an unspecified date sometime after 7/21/00, was vaccinated with a 2nd dose of Hep-B vaccine recombinant (yeast) (lot 634778/1970J). In 10/01, the pt "started showing signs of autism" including not making eye contact, "several" unspecified developmental delays, "a lot of" repetitive behavior and a lack of speech. It was noted that the pt has been evaluated by a physician (details not provided). The pt's signs of autism persisted. Upon internal review, signs of autism was determined to be an "Other Important Medical Event". No further information is available.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Condition aggravated, Injection site induration, Injection site inflammation, Injection site pain
Clinical narrative: Information has been received from a health care professional concerning a 65 year old female who on 11/14/01 was vaccinated in the left arm with a dose of pneumococcal vaccine 23 polyvalent. About 1 hour later, the pt experienced acute pain, swelling, redness and an indurated lesion at the injection site which measured 11cm X 9cm with some smaller lesions surrounding the large one. She was given a Medrol Dosepak and Keflex 250mg q 6 hours for 10 days to cover the cellulitis. The next day, the skin was still indurated, but had decreased in size. On 11/19/01, the pt was checked again and the redness was gone but the indurated area was still 5cm. It was reported that she was taking Vicodin for pain relief. On 12/4/01, the pt reported that her fibromyalgia had flared up probably from the pneumococcal vaccine 23 polyvalent. Upon internal medical review, the pt's cellulitis was considered to be an "Other Important Medical Event". Additional information has been requested. Follow up info from the health care professional reported that the pt had a history of fibromyalgia and occipital nerualgia and was seen frequently in the office for the management of her fibromyalgia. On 11/19/01 the pt was seen again in the office complaining of pain in her left occipital region, from her history of occipital neuralgia, she was administered a nerve block on the left side for the pain. On 11/27/01 the pt was seen in the office and the physician documented that the pt had experienced some cellulitis from the pneumococcal vaccine 23 polyvalent that the pt received on 11/13/01. At this visit it was noted that the pt's left arm had recovered, the redness and induration were completely gone. On 12/4/01 the pt was referred to a neurologist for her complaints of fibromyalgia. Upon internal medical review, the pt's cellulitis was considered an other important medical event (OMIC). Additional info has been requested. Follow up info received on 3/8/02 from the physician's assistant indicated that the pt experienced almost immediate severe pain and fire like burning at the L deltoid injection site. On 11/15/01 she returned to the office with an 11cmx9cm erythematous, warm indurated area with some smaller secondary lesions as well. She had two more follow up visits following. She was treated with Keflex 250mg q 6hr and a medrol dose pack. It was reported that the pt was still complaining of pain in the left deltoid region. Upon internal review, the pt's cellulitis was considered an other important medical event. Additional info has been requested.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a health care professional concerning a 65 year old female who on 11/14/01 was vaccinated in the left arm with a dose of pneumococcal vaccine 23 polyvalent. About 1 hour later, the pt experienced acute pain, swelling, redness and an indurated lesion at the injection site which measured 11cm X 9cm with some smaller lesions surrounding the large one. She was given a Medrol Dosepak and Keflex 250mg q 6 hours for 10 days to cover the cellulitis. The next day, the skin was still indurated, but had decreased in size. On 11/19/01, the pt was checked again and the redness was gone but the indurated area was still 5cm. It was reported that she was taking Vicodin for pain relief. On 12/4/01, the pt reported that her fibromyalgia had flared up probably from the pneumococcal vaccine 23 polyvalent. Upon internal medical review, the pt's cellulitis was considered to be an "Other Important Medical Event". Additional information has been requested. Follow up info from the health care professional reported that the pt had a history of fibromyalgia and occipital nerualgia and was seen frequently in the office for the management of her fibromyalgia. On 11/19/01 the pt was seen again in the office complaining of pain in her left occipital region, from her history of occipital neuralgia, she was administered a nerve block on the left side for the pain. On 11/27/01 the pt was seen in the office and the physician documented that the pt had experienced some cellulitis from the pneumococcal vaccine 23 polyvalent that the pt received on 11/13/01. At this visit it was noted that the pt's left arm had recovered, the redness and induration were completely gone. On 12/4/01 the pt was referred to a neurologist for her complaints of fibromyalgia. Upon internal medical review, the pt's cellulitis was considered an other important medical event (OMIC). Additional info has been requested. Follow up info received on 3/8/02 from the physician's assistant indicated that the pt experienced almost immediate severe pain and fire like burning at the L deltoid injection site. On 11/15/01 she returned to the office with an 11cmx9cm erythematous, warm indurated area with some smaller secondary lesions as well. She had two more follow up visits following. She was treated with Keflex 250mg q 6hr and a medrol dose pack. It was reported that the pt was still complaining of pain in the left deltoid region. Upon internal review, the pt's cellulitis was considered an other important medical event. Additional info has been requested.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Neuropathy peripheral, Pain, Paralysis, Pyrexia
Clinical narrative: The pt developed severe fever, chills 3 weeks after vaccines followed by neuritis and peripheral neuropathy in left arm and paralysis of left thumb and index finger. Annual follow up states patient's strength in thumb and index finger at about 50%. Continued pain in forearm and muscle loss near wrist.
Age: 3.25
Sex: M
Vaccine: VARCEL
Symptoms: Cough, Dyspnoea, Hypersensitivity, Swelling face, Wheezing
Clinical narrative: 45 minutes, post vax, the pt developed acute shortness of breath, wheezing, a cough and facial swelling. The pt was treated with albuterol nebulizer, Prednisone, Benadryl and Pepcid and was admitted.
Age: 38.0
Sex: M
Vaccine: LYME
Symptoms: Arthralgia, Arthritis, Hearing impaired, Hypoaesthesia, Memory impairment
Clinical narrative: The pt developed neck pain, over all joint pain, wrist pain, weakness in limbs, numbness, problems chewing, hip pain, vision problems, hearing problems and memory problems. Annual follow up information states patient still continues to have pains and aches in wrists, neck, hips, shoulders, arms and jaw.
Age: 38.0
Sex: M
Vaccine: LYME
Symptoms: Muscular weakness, Neck pain, Oral intake reduced, Pain, Visual disturbance
Clinical narrative: The pt developed neck pain, over all joint pain, wrist pain, weakness in limbs, numbness, problems chewing, hip pain, vision problems, hearing problems and memory problems. Annual follow up information states patient still continues to have pains and aches in wrists, neck, hips, shoulders, arms and jaw.
Age: 0.2
Sex: M
Vaccine: PNC
Symptoms: Apnoea, Heart rate increased
Clinical narrative: Approx. 1 hour, post vax, the pt's heart rate decreased (per monitor). Apnea spells starting occurring. He was on 1/4 O2.
Sex: M
Vaccine: HEP
Symptoms: Encephalitis, Neurological symptom
Clinical narrative: The pt developed ADEM (Acute disseminating encephalomyelitis), 2-3 weeks, after the vaccine. Doc 210871 reports residual neurological symptoms.
Age: 0.2
Sex: F
Vaccine: DTAP, HBHEPB, IPV
Symptoms: Dyspnoea, Pallor
Clinical narrative: Mom states that the pt was in a car seat carrier and she went very pale. She also noted that the pt seemed to be gasping for air. Mom described the event as "shock-like". This lasted approx. 2 minutes. After picking her up, she "pulled out of it". No treatment was sought.
Age: 1.5
Sex: F
Vaccine: DTAP, HIBV, IPV
Symptoms: Febrile convulsion
Clinical narrative: On 12/31/01, the child received vaccines and on the same night, her temperature was 103F and she had a seizure. The child was seen in ER and discharged. Dx'd with a febrile seizure.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Eyelid oedema, Pain, Pruritus
Clinical narrative: Had MMR on Thursday, 12/27/01 at about 13:00 and on Sunday, 12/30/01, at about 01:00, noticed redness, swelling of eyelids, burning and itching of face, chest at trunk. Took Benadryl and got no relief. Called the health dept on 12/31/01. Please note: had Measles only vaccine on 7/6/67 and Rubella only on 3/6/90.
Age: 0.3
Sex: F
Vaccine: DTAP, HBHEPB, IPV
Symptoms: Pyrexia, Swelling face
Clinical narrative: 3 to 4 days, post vax, the sitter noted baby's face was very swollen. She also had a low-grade fever. This resolved by the time the parent picked up the child.
Age: 77.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site inflammation, Injection site warmth, Pruritus
Clinical narrative: Within 2 hours, noted itching at the vaccination site. Within 12 hours, noted redness and warmth about the site. The next day there was a large area of inflammation (mostly triceps area). No decreased ROM, no fever and no rash. Treated with ice and Tylenol. Symptoms totally resolved in 72 hours.
Age: 18.0
Sex: M
Vaccine: HEP
Symptoms: Dizziness, Injection site pain, Malaise
Clinical narrative: Client reports dizziness, soreness/pain at the injection site and just not feeling well.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Urticaria
Clinical narrative: Shortly after receiving MMR, the pt had immediate hives over the area of the injection. These then spread to the opposite area and back. He was given 25mg of Benadryl po. On day 2, he had increasing redness/swelling. Rx'd with Prednisone 20mg BID with good recovery.
Age: 1.25
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Infection, Irritability
Clinical narrative: Mom stated on 12/30/00 in the afternoon that she noticed a spot on 1 cheek of face and thought it was like a pimple, but filled with yellow fluid. On 12/31/01, he had about 10 of these on his abdomen. Did not think he ran a fever, but has been cranky. Mother is not aware of any exposure to chickenpox. Advised to contact MD. MD appointment on 1/2/02 and was dx'd with chickenpox.